Significant insights into how proteins in human cells interact and "talk" to one another, have been gained by an European scientist. The new research also indicates that this may lead to a better understanding of how medications work.
Giulio Superti-Furga, a professor at the Centre for Molecular Medicine of the Austrian Academy of Sciences, hopes that such insights may result in more effective therapies.
Liver Cancer - Animation
Liver is the largest organ inside the human body. It performs 500 different functions and processes 720 liters of blood per day. The important functions of the liver, the development of liver cancer and it's symptoms are presented in this interactive.
Advertisement
"Most of the time the mechanism of action of drugs is ill understood and we often do not even know the primary target of the drugs we swallow daily. We do not know how these drugs work at the molecular level, and side effects can have serious consequences," he said.
For his research, Prof. Superti-Furga uses a 'proteomics' approach to understanding precisely how certain proteins that are key drug targets organise themselves in the cell, and how they make complex interactions with often dozens of other proteins.
"Proteomics is a way of joining the dots together to give us the bigger picture," he said.
His team has been investigating a particular enzyme, a tyrosine kinase called Bcr-Abl, which is involved in leukaemia.
The researchers has revealed that a drug is available that acts on the enzyme, but it eventually loses its efficiency as patients become resistant to it.
"We need to understand the relationship between the drug and the target. Can we understand the 3-d protein as a molecular machine much better?" he said.
Superti-Furga's lab in Vienna has used a range of proteomics techniques to isolate the enzyme, and dissect its constituent parts.
They have discovered that the protein exists as a complex of some 46 separate components, and operates as a giant molecular machine, with each part in close communication with the others.
"It is clear that tyrosine kinase inhibitors do not simply inhibit the enzyme, but rather remodel the machine. So drugs do not simply ablate things, they interfere with the equilibria of networks. If we can understand how these proteins interact, in the future people might say we should target this pathway or that network'; by targeting multiple nodes we will be able to maximise the good side effects against the bad side effects," the researcher said.
The team say that their main objective is to develop methods to understand how the human body can recognise invading foreign genetic material, from bacteria or viruses for example, and distinguish it from its own, innate genetic material.
They hope that their work will provide important insights into how the body defends itself against invading organisms.
Superti-Furga made a presentation of his team's work at the European Science Foundation's 3rd Functional Genomics Conference in Innsbruck, Austria, held on 1-4 October.
Source: ANI
RAS/SK
Advertisement
"Proteomics is a way of joining the dots together to give us the bigger picture," he said.
His team has been investigating a particular enzyme, a tyrosine kinase called Bcr-Abl, which is involved in leukaemia.
The researchers has revealed that a drug is available that acts on the enzyme, but it eventually loses its efficiency as patients become resistant to it.
"We need to understand the relationship between the drug and the target. Can we understand the 3-d protein as a molecular machine much better?" he said.
Superti-Furga's lab in Vienna has used a range of proteomics techniques to isolate the enzyme, and dissect its constituent parts.
They have discovered that the protein exists as a complex of some 46 separate components, and operates as a giant molecular machine, with each part in close communication with the others.
"It is clear that tyrosine kinase inhibitors do not simply inhibit the enzyme, but rather remodel the machine. So drugs do not simply ablate things, they interfere with the equilibria of networks. If we can understand how these proteins interact, in the future people might say we should target this pathway or that network'; by targeting multiple nodes we will be able to maximise the good side effects against the bad side effects," the researcher said.
The team say that their main objective is to develop methods to understand how the human body can recognise invading foreign genetic material, from bacteria or viruses for example, and distinguish it from its own, innate genetic material.
They hope that their work will provide important insights into how the body defends itself against invading organisms.
Superti-Furga made a presentation of his team's work at the European Science Foundation's 3rd Functional Genomics Conference in Innsbruck, Austria, held on 1-4 October.
Source: ANI
RAS/SK
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Research News
The discovery deepens our understanding of m6A biology and stress granule formation, with implications for neurodegenerative diseases.
Trouble with sleep and the body's clock may increase your risk for Parkinson's, as per a new study.
New study uncovers a link between nocturnal hot flashes and Alzheimer's risk in menopausal women, suggesting a potential biomarker.
Our discovery revealed that a minority of individuals attributed their chronic pain to their brain's involvement.
Relative Energy Deficiency in Sport syndrome is overlooked by athletes and can be worsened by 'sports culture' due to its perceived short-term performance benefits.
